KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Accumulated Expenses (2016 - 2025)

West Pharmaceutical Services' Accumulated Expenses history spans 17 years, with the latest figure at $135.9 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 84.9% year-over-year to $135.9 million; the TTM value through Dec 2025 reached $135.9 million, up 84.9%, while the annual FY2025 figure was $135.9 million, 84.9% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $135.9 million at West Pharmaceutical Services, up from $111.8 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $135.9 million in Q4 2025 and bottomed at $65.7 million in Q1 2023.
  • The 5-year median for Accumulated Expenses is $81.2 million (2024), against an average of $88.0 million.
  • The largest annual shift saw Accumulated Expenses crashed 33.96% in 2022 before it surged 84.9% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $116.3 million in 2021, then plummeted by 33.96% to $76.8 million in 2022, then surged by 37.89% to $105.9 million in 2023, then crashed by 30.59% to $73.5 million in 2024, then soared by 84.9% to $135.9 million in 2025.
  • Per Business Quant, the three most recent readings for WST's Accumulated Expenses are $135.9 million (Q4 2025), $111.8 million (Q3 2025), and $93.4 million (Q2 2025).